Troglitazone (CS-045)

For research use only.

Catalog No.S8432 Synonyms: Rezulin, Romglizone, Prelay, CS-045, CS045, CS 045, Romozin

3 publications

Troglitazone (CS-045) Chemical Structure

CAS No. 97322-87-7

Troglitazone (Rezulin, Romglizone, Prelay, CS045, Romozin) is a potent agonist for the peroxisome proliferator-activated receptor-(PPAR) that is a ligand activated transcription factor regulating cell differentiation and growth. Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells. Troglitazone prevents RSL3-induced ferroptosis and lipid peroxidation in Pfa1 cells.

Selleck's Troglitazone (CS-045) has been cited by 3 publications

Purity & Quality Control

Choose Selective PPAR Inhibitors

Biological Activity

Description Troglitazone (Rezulin, Romglizone, Prelay, CS045, Romozin) is a potent agonist for the peroxisome proliferator-activated receptor-(PPAR) that is a ligand activated transcription factor regulating cell differentiation and growth. Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells. Troglitazone prevents RSL3-induced ferroptosis and lipid peroxidation in Pfa1 cells.
Targets
Ferroptosis [6]
()
PPAR [1]
()
In vitro

Troglitazone significantly inhibits cell growth by cell cycle arrest and apoptotic cell death. Troglitazone also downregulates surface expression of CD97, a novel dedifferentiation marker, in FTC-133 cells and upregulated sodium iodide symporter (NIS) mRNA in TPC-1 and FTC-133 cells. Troglitazone, a PPARγ agonist, induces antiproliferation and redifferentiation in thyroid cancer cell lines[1]. Troglitazone induces Erk phosphorylation in human prostate cancer cells via a PPARγ-independent signaling pathway[2]. TGZ(Troglitazone) up-regulates nitric oxide synthesis, induces the p53 pathway, inhibits cholesterol biosynthesis, induces p21 cyclin-dependent kinase inhibitor, has antioxidant function, and activates extracellular signal-regulated protein kinase (ERK) in a PPARγ-independent manner. TGZ induces Egr-1 expression by transcriptional and post-transcriptional regulation. Egr-1 induction by TGZ results in the increase of binding affinity and transactivation of the promoter containing Egr-1 consensus sequences, thereby possibly inducing other anti-tumorigenic proteins[3].

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
3T3-L1 cells NEG2RnVHfW6ldHnvckBie3OjeR?= MVPF[oZm[3SrdnWgZ49v[2WwdILheIlwdiCob4KgOVAmKGWwaHHuZ4Vu\W62IH;mJIlve3WuaX6tbY5lfWOnZDD0dolodHmlZYLp[IUh[WOldX31cIF1cW:wIHnuJFNVOy2OMTDj[YxteyxiRVO1NF0xNjF|IN88US=> NGT2bZM6PTl7MkSx
PC12 cells NEnrSINRem:uaX\ldoF1cW:wIHHzd4F6 NYDZN4c{S2:wY3XueJJifGmxbjDy[ZF2cXKnZDDmc5IhPTBnIHnubIljcXSrb36gc4Yh[2WubDDwdo9tcW[ncnH0bY9vKGmwIGDDNVIh[2WubIOgeZNqdmdic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhUUN3ME2xOUDPpG1? NWPRUGtZOTVzMEm2OFg>
A549 NXXnZ3U{T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M{\UV2lvcGmkaYTpc44hd2ZiaIXtZY4hdHWwZzDjZY5k\XJiY3XscEBtcW6nIDjBOVQ6MSCkeTC1NEUhcW5ic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xOUDPxE1? M2PEOFE2PDV2MkO0
3T3L1 cells NFzke4VHfW6ldHnvckBie3OjeR?= M1uz[2lv[3KnYYPlJIlvKDJvZHXvfJlodHWlb4PlJJVxfGGtZTDpckBud3W|ZTCzWFNNOSClZXzsd{BifCB|IIXNJIJ6KGyrcYXp[EB{[2mwdHnscIF1cW:wIHPveY51\XJ? Ml3iNVg1Pzd3MEe=
ST-13 cells M{fHe2Z2dmO2aX;uJIF{e2G7 MVy1JO69VQ>? M{fFfFEyKGSjeYO= NFTufVZKdmS3Y4Tpc44hd2ZicILlZYRqeG:leYTlJIRq\m[ncnXueIlifGmxbjDpckBud3W|ZTDTWE0yOyClZXzsd{Bie3Onc4Pl[EBieyCuaYDp[EBi[2O3bYXsZZRqd25iYYSgOUB2VSC5aYTobY4hOTFiZHH5d{BjgSCxaXygdoVlNXO2YXnubY5oKHKnbHH0bZZmKHSxIHPvcpRzd2x? MnjQNVkzPjh3OEe=
HEK293 cells M4PTS2Z2dmO2aX;uJIF{e2G7 NXe1SVJlSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhemWlZYD0c5IhcW62ZYLhZ5Rqd25id3n0bEB{fGW{b3nkJJJm[2WydH;yJINw[WO2aY\heI9zNTFiYomgSXlHWCCkYYPl[EBz\XCxcoTldkBo\W6nIHHzd4F6 NHzNWnUyPjZ6MEG1PS=>
MA104 cells NWTmdXZMS3m2b4TvfIlkcXS7IHHzd4F6 M16y[lI1KGh? M4m3OmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KG2xbnvlfUBOSTFyNDDj[YxteyCjZoTldkAzPCCqcoOsJHRFPTB;MUiuOUDPxE1? MnLyNlI{PjV2MUG=
MDA-MB-231 cells MkDFVJJwdGmoZYLheIlwdiCjc4PhfS=> M{XIOlI1KGh? NUjjSGZUSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkhcG:{bX;u[U1qdmSncHXu[IVvfCCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDseY1qdmW|Y3XueEBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0yPS55IN88US=> NYfyWG9ZOjJ2MEm5Olg>
MCF7 cells MlzZVJJwdGmoZYLheIlwdiCjc4PhfS=> M3vEdFI1KGh? M3vqNGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIhwem2xbnWt[IVx\W6mZX70JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IHz1cYlv\XOlZX70JINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVM2NjRizszN NHj1VGYzOjRyOUm2PC=>
HepG2 cells MXvGeY5kfGmxbjDhd5NigQ>? NWjER5NCOjBiaB?= MkTOWJJidnOjY4TpeoF1cW:wIH;mJGdCVDRvZoXz[YQhWFCDUnfhcY1iKEyERDDlfJBz\XO|ZXSgbY4hUGWyR{KgZ4VtdHNiYX\0[ZIhOjBiaILzJIJ6KGy3bXnu[ZNk\W6lZTDhd5NigSxiRVO1NF0xNjd|IN88US=> NFPwUZkzOjN6MUC0Oy=>
LNCAP cells Mn3SR5l1d3SxeHnjbZR6KGG|c3H5 NV3EUWhNOjRiaB?= MVfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMUmNCWCClZXzsd{Bi\nSncjCyOEBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUKyJO69VQ>? MoLmNlI2PDZ{MEi=
PC3 cells NIfodppEgXSxdH;4bYNqfHliYYPzZZk> M1u1R|I1KGh? NYDITYd7S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWEN|IHPlcIx{KGGodHXyJFI1KGi{czDifUBOXFRiYYPzZZktKEmFNUC9N|Ah|ryP Mk\vNlI2PDZ{MEi=
HepG2 cells NUXZ[mNsTnWwY4Tpc44h[XO|YYm= NGjVcGk2OCEQvF2= M3LyVlI1KGh? NX;rR|JEUW6mdXP0bY9vKG:oIIC1N{Bxem:2ZXnuJIxmfmWuIHnuJIh2dWGwIFjldGczKGOnbHzzJIF1KDVyIIXNJJVxKHSxIEK0JIhzeyCkeTDpcY12dm:kbH;0JIFv[Wy7c3nz MWGyOVg2OTl|OR?=
CV-1 cells MXnGeY5kfGmxbjDhd5NigQ>? MnXqRYN1cX[jdHnvckBw\iCyZYLvfIl{d22nIIDyc4xq\mW{YYTvdkBi[3SrdnH0[YQhemWlZYD0c5Ih\2GvbXGgcYVie3W{ZXSgZpkhcW6mdXP0bY9vKG:oIEWwKUBw\iCvYYjpcZVuKGGua3HsbY5mKHCqb4PwbIF1[XOnIHHjeIl3cXS7LDD0doFve2[nY4Tpc44h[XO|YYmgbY4hS1ZvMTDj[YxteyxiRVO1NF0xNjV|N{CzJO69VQ>? Ml\OPVg{PjZ{MB?=
CHO cells MUTGeY5kfGmxbjDhd5NigQ>? MXyyOEBp MUXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hS0iRIHPlcIx{KGOxLYTyZY5{\mWldHXkJJdqfGhicFfMN{1RWFKHMz3UT{1tfWNiYYPz[ZN{\WRiYYOgeJJidnOjY4TpeoF1cW:wIHHmeIVzKDJ2IHjyd{BjgSCoaYLl[ox6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkS0JO69VQ>? NIHW[Y4zOjN2Mk[yOC=>
HepG2 cells NGfoOVdHfW6ldHnvckBie3OjeR?= MWOwMlUuOTJwNTFOwG0> MVzB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBqdiCqdX3hckBJ\XCJMjDj[YxteyCjc4Pld5Nm\CCjczDkc5dvNXKnZ4XsZZRqd25ib3[g[4x2[2:|ZT22MZBpd3OyaHH0ZZNmKGG2IECuOUB1dyBzMj61JJVOKGK7IILlZYwufGmvZTDQR3IhdWW2aH;k MUSyNlM1OjZ{NB?=
3T3L1 cells NGKzVmZHfW6ldHnvckBie3OjeR?= MV7B[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBqdiCvb4Xz[UA{XDOOMTDj[YxteyxiRVO1NF0yKM7:TR?= M1fCS|IyPDl|MEez
HepG2 cells MoDpSpVv[3Srb36gZZN{[Xl? NEL0[4gxNjVvMUKuOUDPxE1? M3XIUWFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIHj1cYFvKEincFeyJINmdGy|IHHzd4V{e2WmIHHzJIRwf25vcnXneYxifGmxbjDv[kBxcG:|cHjv[Y5wdHC7coX2ZZRmKGOjcnLvfJlscW6jc3WgZZQhOC53IITvJFEzNjVidV2gZpkhemWjbD30bY1mKFCFUjDt[ZRpd2R? NFz5N5UzOjN2Mk[yOC=>
HepG2 cells NYDyd2FbTnWwY4Tpc44h[XO|YYm= NWrGSWJvSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiaX6gbJVu[W5iSHXwS|Ih[2WubIOgZZN{\XO|ZXSgZZMh\G:5boLl[5Vt[XSrb36gc4YheGixc4Doc4Vvd2yyeYL1eoF1\SClYYLic5h6c2mwYYPlJI1TVkFiYomgVnQuWEOUIHHuZYx6e2m| NH65SYozOjR{NEOwNC=>
HEK293T cells NXLIbGtJTnWwY4Tpc44h[XO|YYm= MlfiTY5pcWKrdHnvckBw\iCvb4Xz[UBK\G9{IITyZY5{\mWldHXkJIlvKEiHS{K5N3Qh[2WubIOgeZNqdmdiTD30dplxfG:yaHHuJIF{KHO3YoP0doF1\SCjc4Pld5Nm\CCjczDrfY52emWwaX7lJIZwem2jdHnvckBi\nSncjC0OUBucW6|IHL5JJNx\WO2cn;wbI91d22ndILpZ{BidmGueYPpd{whUUN3ME20MlUh|pyv M4nkNVI{OTJ{OE[1
HepG2 cells NHzpW|lHfW6ldHnvckBie3OjeR?= Mn;ZRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYYPz[ZN{\WRiYYOg[I94dnKnZ4XsZZRqd25ib3[g[4x2[2:|ZT22MZBpd3OyaHH0ZZNmKG2UTlGgZpkhWlRvUFPSJIFv[Wy7c3nz Mlf4NlI1OjR|MEC=
HEK293 cells MVzGeY5kfGmxbjDhd5NigQ>? M3WxeGFkfGm4YYTpc44hd2ZiUGDBVodidW2jIITyZY5{\mWldHXkJIlvKEiHS{K5N{Bk\WyuczDh[pRmeiBzODDodpMh[nliZnny[YZtgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUu[mG|ZXSgcJVucW6nc3PlcoNmKGG|c3H5JJJmdGG2aY\lJJRwKGOxboTyc4wtKEWFNUC9NE41KM7:TR?= MV[yNVgxODh3Nh?=
rat ventricular myocytes MnPTSpVv[3Srb36gZZN{[Xl? M362b2lvcGmkaYTpc44hd2ZiTD30fZBmKGOjbHPpeY0h[2ijbn7lcEBu\WG|dYLl[EB2e2mwZzD3bI9t\S2lZXzsJJBifGOqIHPsZY1xKGmwIILheEB3\W62cnnjeYxieiCveX;jfZRmeyxiSVO1NF06NjVizszN M2jIfFIzPzZzMECw
HepG2 (DPX-2) cells NWXLeol7TnWwY4Tpc44h[XO|YYm= NUHleoxJOjRiaB?= NETpZ3JC[3SrdnH0bY9vKG:oIHj1cYFvKFC[UjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiKFTQXE0zMSClZXzsd{Bie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gR3lRO0F2IHHmeIVzKDJ2IHjyd{BjgSCudX3pcoV{[2WwdDDhcoFtgXOrczygSWM2OD14Lkmg{txO NX7tcoF7OjB7Nk[wOFM>
CV1 cells M4f2XmZ2dmO2aX;uJIF{e2G7 NYTHOpdCXHKjboPhZ5RqfmG2aX;uJI9nKGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iYX\ybYNidiCpcnXlckBud26tZYmgR3YyKGOnbHzzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkSg{txO NIX4SokzOjV5OUSyNC=>
CHO cells M{TxSGZ2dmO2aX;uJIF{e2G7 M2rTWGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gdoVkd22kaX7hcpQhWFCDUnfhcY1iKGW6cILld5Nm\CCrbjDDTG8h[2WubIOgZ491emGwc3\lZ5Rm\CC5aYToJJBIVDNvUGDSSVMuXEtvbIXjJJJmeG:{dHXyJIF{e2W|c3XkJIF{KGKndHGt[4Ft[WO2b4Pp[IF{\SCjY4Tpeol1gSCjdDDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDiZZNm\CC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD60OEDPxE1? M2LBeVIzPDJ2M{Cw
HepG2 cells NGD6bphHfW6ldHnvckBie3OjeR?= MUnUdoFve2GldHn2ZZRqd25ib3[gS2FNPC2odYPl[EBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIITyZY5{\mWldHXkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGGodHXyJFIxKGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC55MjFOwG0> M4rBdVI{ODNzNUm2
HEK293 cells MVTGeY5kfGmxbjDhd5NigQ>? MoTVNVAh|ryP MmjONlQhcA>? NX64NnFEXHKjboPhZ5RqfmG2aX;uJI9nKFCSQWKt[4FudWFidILhcpNn\WO2ZXSgbY4hUEWNMkmzJINmdGy|IHH0JFExKHWPIHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= NITWUnIzOjV5OUS4OC=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
ASCT2 / GLS1 ; 

PubMed: 25872876     


Protein expression of the glutamine transporter, ASCT2, glutaminase, GLS1, and β-actin within H460, HeLa 229 and TKO MEF cells in response to varying concentrations of troglitazone for 48 hours. Shown are representative images from three independent experiments.

c-Myc; 

PubMed: 25872876     


Expression of c-Myc and β-actin within H460, HeLa 229 and TKO MEF cells in response to 48 hour incubation with varying troglitazone concentrations was determined by Western blot analysis as described in the Materials and Methods. Shown are representative images from three independent experiments.

25872876
Growth inhibition assay
Cell viability; 

PubMed: 25872876     


After 48 hours of treatment with varying concentrations of troglitazone, H460 viable cell number was determined using trypan blue staining and hemocytometer enumeration. Data are presented as percent of vehicle and shown as the mean ± s.d. from three independent experiments. * p < 0.05, compared to vehicle control.

25872876
In vivo

Troglitazone is an effective antidiabetic drug with a fundamentally new mechanism of action. However, within a year after its widespread use, individual cases of liver injury and failure are reported[5]. TGZ significantly inhibits tumor growth of human colorectal cancer cells (HCT-116), human breast cancer cells (MCF-7), and human prostate cancer cells (PC-3) in immunodeficient mice[3]. Troglitazone attenuates pancreatic damage and inflammation in experimental chronic pancreatitis[4].

Protocol

Cell Research:

[1]

- Collapse
  • Cell lines: Thyroid cancer cell lines TPC-1, FTC-133, FTC-236, FTC-238, XTC-1 and ARO82-1 cell lines
  • Concentrations: 5, 10, 20, 40 μM
  • Incubation Time: 0, 2, 4, and 6 days
  • Method:

    Growth experiments are done in a 96-well plate in hexaplicate. Cells at 85%-100% confluency are harvested with 1×Trypsin/EDTA solution and seeded into a 96-well plate at 3-5×103 cells per well depending upon growth rate and maintained in 200 μL H5 medium in a humidified incubator. After 24 hours, cells are incubated with different concentrations of troglitazone and the media was changed daily. Colorometric dimethyl-thiazol-diphenyltetrazolium bromide (MTT) proliferation assays are performed at 0, 2, 4, and 6 days after treatment. MTT (400 μg/mL) is added to each well and incubated for 3 hours. It is solubilized with 0.04 N HCl/iso-propanol/3% SDS and incubated for 1 hour. The optical densities in the 96-well plates are determined using an enzyme-linked immunosorbent assay (ELISA) microplate reader at 595 nm/620 nm.


    (Only for Reference)
Animal Research:

[4]

- Collapse
  • Animal Models: C57BL/6 mice
  • Dosages: 0.2% (with chow)
  • Administration: oral administration
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 88 mg/mL warmed (199.3 mM)
Ethanol 15 mg/mL warmed (33.97 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
1% CMC Na
For best results, use promptly after mixing.
30mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 441.54
Formula

C24H27NO5S

CAS No. 97322-87-7
Storage powder
in solvent
Synonyms Rezulin, Romglizone, Prelay, CS-045, CS045, CS 045, Romozin
Smiles CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

PPAR Signaling Pathway Map

Related PPAR Products

Tags: buy Troglitazone (CS-045) | Troglitazone (CS-045) ic50 | Troglitazone (CS-045) price | Troglitazone (CS-045) cost | Troglitazone (CS-045) solubility dmso | Troglitazone (CS-045) purchase | Troglitazone (CS-045) manufacturer | Troglitazone (CS-045) research buy | Troglitazone (CS-045) order | Troglitazone (CS-045) mouse | Troglitazone (CS-045) chemical structure | Troglitazone (CS-045) mw | Troglitazone (CS-045) molecular weight | Troglitazone (CS-045) datasheet | Troglitazone (CS-045) supplier | Troglitazone (CS-045) in vitro | Troglitazone (CS-045) cell line | Troglitazone (CS-045) concentration | Troglitazone (CS-045) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID